Former President Joe Biden diagnosed with aggressive prostate cancer that has spread to bones. Hormone-sensitive, high Gleason score cancer poses treatment challenges but remains manageable with hormone therapy. Biden's diagnosis brings attention to advanced prostate cancer treatment and related health policy discussions.

Atrium Health Levine Cancer's Financial Toxicity Tumor Board mitigates financial distress among cancer patients, improving treatment outcomes and reducing insurance claim denials. A five-year study highlights its efficacy and suggests it as a best practice for cancer centers.